Model
Edge
Alnylam Pharmaceuticals, Inc.
0001381994
Filing Type
144
Filing Date
8/13/2025
Updated
8/14/25, 2:17 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities